PCM
CERE

PenderFund Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

PenderFund Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,600
Closed -$481K – 166
2024
Q2 		$481K Sell
8,600
-8,200
-49% -$459K 0.13% 60
2024
Q1 		$962K Buy
16,800
+7,400
+79% +$424K 0.25% 44
2023
Q4 		$528K Buy
+9,400
New +$528K 0.17% 54